Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

NHC Reports 2022 Year End Earnings

NHC

National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues and grant income for the year ended December 31, 2022 totaled $1,085,738,000 compared to $1,074,302,000 for the year ended December 31, 2021, an increase of 1.1%. The net operating revenues increase in 2022 was despite a reduction in government stimulus income of $51.9 million compared to 2021.

For the year ended December 31, 2022, the reported GAAP net income attributable to NHC was $22,445,000 compared to $138,590,000 for the 2021 year. Excluding the unrealized gains and losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the year ended December 31, 2022 was $37,323,000 compared to $62,645,000 for the 2021 year (*). The decrease in non-GAAP earnings for 2022 compared to 2021 was primarily due to the $51.9 million decrease of government stimulus income recorded. GAAP diluted earnings per share were $1.45 compared to $8.99 for the years ended December 31, 2022 and 2021, respectively. Adjusted diluted earnings per share were $2.42 compared to $4.06 for the years ended December 31, 2022 and 2021, respectively (*).

For the quarter ended December 31, 2022, the reported GAAP net income attributable to NHC was $6,353,000 compared to $15,788,000 for the same period in 2021. Excluding the unrealized gains and losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended December 31, 2022 was $11,046,000 compared to $15,801,000 for the same period in 2021 (*). The decrease in non-GAAP earnings for the quarter ended December 31, 2022 compared to the fourth quarter of 2021 was primarily due to the $14.5 million decrease of government stimulus income recorded. The GAAP diluted earnings per share were $0.41 compared to $1.02 for the quarters ended December 31, 2022 and 2021, respectively. Adjusted diluted earnings per share were $0.72 and $1.02 for the quarters ended December 31, 2022 and 2021, respectively (*).

(*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items.

About NHC

NHC affiliates operate for themselves and third parties 68 skilled nursing facilities with 8,726 beds. NHC affiliates also operate 23 assisted living communities with 1,181 units, five independent living communities with 475 units, three behavioral health hospitals, 35 homecare agencies, and 29 hospice agencies. NHC’s other services include Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

Forward-Looking Statements

Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q, and 10-K. All forward-looking statements represent NHC’s best judgment as of the date of this release.

Consolidated Statements of Operations
(in thousands, except share and per share amounts)
Three Months Ended Year Ended
December 31 December 31

2022

2021

2022

2021

Revenues and grant income:
Net patient revenues

$

252,424

$

256,894

$

1,029,085

$

965,542

Other revenues

11,612

11,484

45,196

45,400

Government stimulus income

517

15,056

11,457

63,360

Net operating revenues and grant income

264,553

283,434

1,085,738

1,074,302

Costs and expenses:
Salaries, wages and benefits

167,341

182,800

686,169

666,063

Other operating

67,365

62,543

289,372

266,754

Facility rent

10,207

10,381

40,977

40,818

Depreciation and amortization

10,478

10,151

40,489

40,672

Interest

112

188

563

845

Impairment/(recovery) of assets

-

8,225

(3,728

)

8,225

Total costs and expenses

255,503

274,288

1,053,842

1,023,377

Income from operations

9,050

9,146

31,896

50,925

Non-operating income

2,690

2,529

11,141

17,774

Gain on acquisition of equity method investment

-

-

-

95,202

Unrealized gains/(losses) on marketable equity securities

(4,327

)

9,364

(15,806

)

(13,863

)

Income before income taxes

7,413

21,039

27,231

150,038

Income tax provision

(1,839

)

(5,044

)

(7,254

)

(10,951

)

Net income

5,574

15,995

19,977

139,087

Net (income)/loss attributable to noncontrolling interest

779

(207

)

2,468

(497

)

Net income attributable to National HealthCare Corporation

$

6,353

$

15,788

$

22,445

$

138,590

Net income per common share
Basic

$

0.41

$

1.03

$

1.46

$

9.03

Diluted

$

0.41

$

1.02

$

1.45

$

8.99

Weighted average common shares outstanding
Basic

15,326,680

15,364,302

15,410,222

15,347,129

Diluted

15,358,488

15,440,633

15,447,211

15,416,716

Dividends declared per common share

$

0.57

$

0.55

$

2.26

$

2.11

Balance Sheet Data Dec. 31 Dec. 31
(in thousands)

2022

2021

Cash, cash equivalents and marketable securities

$

182,589

$

256,025

Restricted cash, cash equivalents and marketable securities

158,067

175,884

Current assets

353,932

426,638

Property and equipment, net

506,532

520,996

Total assets

1,275,450

1,403,396

Current liabilities

197,887

263,201

NHC stockholders' equity

874,276

903,004

Selected Operating Statistics
Three Months Ended Year Ended
December 31 December 31

2022

2021

2022

2021

Skilled Nursing Per Diems:
Medicare

$

544.11

$

530.32

$

541.23

$

529.03

Managed Care

482.99

439.61

439.07

414.11

Medicaid

236.86

224.61

232.22

225.40

Private Pay and Other

265.55

259.96

267.50

255.60

Average Skilled Nursing Per Diem

$

310.82

$

297.62

$

304.04

$

297.19

Skilled Nursing Patient Days:
Medicare

82,965

91,056

341,926

362,080

Managed Care

51,003

56,133

214,826

239,726

Medicaid

284,208

317,610

1,204,139

1,213,565

Private Pay and Other

157,174

158,577

646,651

597,802

Total Skilled Nursing Patient Days

575,350

623,376

2,407,542

2,413,173

The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts):
Three Months Ended Year Ended
December 31 December 31

2022

2021

2022

2021

Net income attributable to National Healthcare Corporation

$

6,353

$

15,788

$

22,445

$

138,590

Non-GAAP adjustments
Unrealized (gains)/losses on marketable equity securities

4,327

(9,364

)

15,806

13,863

Operating results for newly opened operations not at full capacity (1)

1,383

442

5,416

922

Gain on acquisition of equity method investment

-

-

-

(95,202

)

Impairment/(recovery) of assets

-

8,225

(3,728

)

8,225

Stock-based compensation expense

632

715

2,612

2,620

Income tax benefit on non-GAAP adjustments

(1,649

)

(5

)

(5,228

)

(6,373

)

Non-GAAP Net income

$

11,046

$

15,801

$

37,323

$

62,645

GAAP diluted earnings per share

$

0.41

$

1.02

$

1.45

$

8.99

Non-GAAP adjustments
Unrealized (gains)/losses on marketable equity securities

0.21

(0.45

)

0.76

0.67

Operating results for newly opened operations not at full capacity (1)

0.07

0.02

0.26

0.04

Gain on acquisition of equity method investment

-

-

-

(6.16

)

Impairment/(recovery) of assets

-

0.40

(0.18

)

0.39

Stock-based compensation expense

0.03

0.03

0.13

0.13

Non-GAAP diluted earnings per share

$

0.72

$

1.02

$

2.42

$

4.06

(1) The newly opened operations not at full capacity for the 2022 period presented consisted of operations opened from 2020 through 2022. This consisted of two behavioral health hospitals, one homecare agency, and one hospice agency. The newly opened operations for the 2021 period presented consisted of operations opened from 2019 through 2021. The 2021 period consisted of one memory care facility and two behavioral health hospitals.

Tags: